Studies on kallikrein: failure of some anti-inflammatory drugs to affect release of kinin.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D007611:Aprotinin / Q000494:pharmacology; D001241:Aspirin / Q000494:pharmacology; D002417:Cattle; D002738:Chloroquine / Q000494:pharmacology; D004792:Enzyme Precursors / Q000378:metabolism*; D004798:Enzymes / Q000494:pharmacology; D005260:Female; D005439:Flufenamic Acid / Q000494:pharmacology; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007610:Kallikreins / Q000378:metabolism*; D007705:Kinins / Q000032:analysis* / Q000378:metabolism*; D010248:Paramethasone / Q000494:pharmacology; D010648:Phenylacetates / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D051381:Rats; D014361:Trypsin Inhibitors / Q000494:pharmacology; D014599:Uterus / Q000187:drug effects; D062367:ortho-Aminobenzoates / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D004792:Enzyme Precursors; D004798:Enzymes; D007705:Kinins; D010648:Phenylacetates; D014361:Trypsin Inhibitors; D062367:ortho-Aminobenzoates; D005439:Flufenamic Acid; D002738:Chloroquine; D007611:Aprotinin; D007610:Kallikreins; D010653:Phenylbutazone; D001241:Aspirin; D010248:Paramethasone